For example, in a mouse model of Parkinson’s disease, delivery of an adenovirus construct by CRISPR-SAM via injection into the brain resulted in successful reprogramming of astrocytes into functional neurons through the activation of differentiation factors Ascl1, Lmx1a, and Nr4a2 [106]. This evidence concerns the gene LMX1A and Parkinson disease.